Quick Answer
AVANOS MEDICAL, INC. reported Net Income Loss of -$72.90 million for the year ending 2025.
- AVANOS MEDICAL, INC. showed an increase of +81.4% in Net Income Loss from 2024 to 2025.
- This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $47.90 million | Q1 2014: $41.40 million | Q2 2014: -$4.50 million | Q3 2014: -$7.40 million | Q1 2015: $21.70 million | Q2 2015: $8.00 million | Q3 2015: -$470.50 million | Q1 2016: $14.20 million | Q2 2016: $6.50 million | Q3 2016: $9.10 million | Q1 2017: $12.80 million | Q2 2017: $17.10 million | Q3 2017: $16.60 million | Q1 2018: $20.20 million | Q2 2018: $35.30 million | Q3 2018: $4.20 million | Q1 2019: -$20.30 million | Q2 2019: -$8.00 million | Q3 2019: -$11.50 million | Q1 2020: $3.70 million | Q2 2020: -$3.00 million | Q3 2020: $19.30 million | Q1 2021: -$8.40 million | Q2 2021: $38.50 million | Q3 2021: -$35.30 million | Q1 2022: $5.40 million | Q2 2022: $12.50 million | Q3 2022: $15.70 million | Q1 2023: -$500.0 thousand | Q2 2023: -$68.10 million | Q3 2023: -$3.70 million | Q1 2024: -$900.0 thousand | Q2 2024: $1.80 million | Q3 2024: $4.30 million | Q1 2025: $6.60 million | Q2 2025: -$76.80 million | Q3 2025: -$1.40 million.
- Over the full 14 years of available data (2012 to 2025), AVANOS MEDICAL, INC.'s Net Income Loss has declined by 147.8%.
- Historical annual values: Fiscal year 2025: -$72.90 million | Fiscal year 2024: -$392.10 million | Fiscal year 2023: -$61.80 million | Fiscal year 2022: $50.50 million | Fiscal year 2021: $6.30 million | Fiscal year 2020: -$29.00 million | Fiscal year 2019: -$45.90 million | Fiscal year 2018: $57.50 million | Fiscal year 2017: $79.30 million | Fiscal year 2016: $39.80 million | Fiscal year 2015: -$426.30 million | Fiscal year 2014: $27.10 million | Fiscal year 2013: $154.60 million | Fiscal year 2012: $152.60 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: